NEW YORK, Oct. 14, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Churchill Capital Corp. II ("CCX" or the "Company") (NYSE: CCX) in connection with the Company's proposed merger with Software Luxembourg Holding S.A. ("Skillsoft"), a privately-held digital learning and talent management solutions company. Under the terms of the acquisition agreement, CCX will acquire Skillsoft through a reverse merger that will result in Skillsoft becoming a publicly-traded company on the New York Stock Exchange. The proposed transaction values the combined company at approximately $1.3 billion. Upon closing, publicly-traded Skillsoft will acquire IT company Global Knowledge Training LLC for approximately $233 million, bringing the value of the entire transaction to nearly $1.5 billion.
If you own CCX shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:
Or please contact: Joshua Rubin, Esq. WeissLaw LLP 1500 Broadway, 16th Floor New York, NY 10036 (212) 682-3025 (888) 593-4771 [email protected]
WeissLaw is investigating whether CCX's board acted in the best interest of CCX's public shareholders in agreeing to the proposed transaction, whether the board was fully informed as to the valuation of Skillsoft, and whether all information regarding the valuation of the transaction will be fully and fairly disclosed to CCX public shareholders.
WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at [email protected]